5McCullough P A,Nowak R M,McCord J,et al.B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure:analysis from Breathing Not Properly (BNP) Multinational study[J].Circulation,2002,106(4):419-422.
6Tsutamoto T,Wada A,Meada K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure-prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction[J].Circulation,1997.96(2):509-516.
7Tsutamoto T,Wada A,Maeda K,et al.Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction-comparison with angiotensin Ⅱ and endothelin-1[J].Eur Heart J,1999,20(24):1799-1807.
8Maeda K,Tsutamoto T,Wada A,et al.High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure[J].J Am Coll Cardiol,2000,36(5):1587-1593.
9Harrison A,Morrison L K,Krishnaswamy P,et al.B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J].Ann Emerg Med,2002,39(2):131-138.
10Maisel A S.Practical approaches to treating patients with acute decompensated heart failure[J].J Card Fail,2001,7(2 suppl 1):13-17.
